Model structure of human APOBEC3G.

Model structure of human APOBEC3G.

APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G) has antiretroviral activity associated with the hypermutation of viral DNA through cytosine deamination. APOBEC3G has two cytosine deaminase (CDA) domains; the catalytically inactive amino-terminal domain of APOBEC3G (N-C...

Full description

Bibliographic Details
Main Authors:	Kun-Lin Zhang, Bastien Mangeat, Millan Ortiz, Vincent Zoete, Didier Trono, Amalio Telenti, Olivier Michielin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2007-04-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC1849894?pdf=render

Similar Items

Characterization of APOBEC3G binding to 7SL RNA
by: Lakkaraju Asvin, et al.
Published: (2008-07-01)

APOBEC3G-depleted resting CD4+ T cells remain refractory to HIV1 infection.
by: Francesca R Santoni de Sio, et al.
Published: (2009-08-01)

The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription
by: Turelli Priscilla, et al.
Published: (2006-08-01)

Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
by: Stavrou, Spyridon, et al.
Published: (2014)

The roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.
by: Jing Ma, et al.
Published: (2013-01-01)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
by: Yunjie Duan, et al.
Published: (2022-10-01)

Stem-loop structure preference for site-specific RNA editing by APOBEC3A and APOBEC3G
by: Shraddha Sharma, et al.
Published: (2017-12-01)

Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
by: Michel Henry, et al.
Published: (2009-01-01)

The restriction of zoonotic PERV transmission by human APOBEC3G.
by: Stefán R Jónsson, et al.
Published: (2007-09-01)

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome
by: Ebrahimi Diako, et al.
Published: (2012-12-01)

Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
by: Michael J Wichroski, et al.
Published: (2006-05-01)

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
by: Russell, R, et al.
Published: (2007)

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
by: Armitage, A, et al.
Published: (2014)

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
by: Walker Robert C, et al.
Published: (2009-11-01)

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
by: Russell, R, et al.
Published: (2009)

Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
by: Michael Letko, et al.
Published: (2015-12-01)

Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.
by: Kristin Stieler, et al.
Published: (2010-07-01)

APOBEC3G targets human T-cell leukemia virus type 1
by: Imada Kazunori, et al.
Published: (2005-05-01)

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
by: Friew Yeshitila N, et al.
Published: (2009-06-01)

Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations
by: Yasha Butt, et al.
Published: (2024-03-01)

Structural basis of sequence-specific RNA recognition by the antiviral factor APOBEC3G
by: Hanjing Yang, et al.
Published: (2022-12-01)

Crystal structures of APOBEC3G N-domain alone and its complex with DNA
by: Xiao Xiao, et al.
Published: (2016-08-01)

Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G
by: Ying Tong, et al.
Published: (2022-05-01)

APOBEC3G levels predict rates of progression to AIDS
by: Wu Hulin, et al.
Published: (2007-03-01)

The cellular source for APOBEC3G's incorporation into HIV-1
by: Guo Fei, et al.
Published: (2011-01-01)

APOBEC3G & HTLV-1: Inhibition without deamination
by: Strebel Klaus
Published: (2005-05-01)

T-cell receptors binding orientation over peptide/MHC class I is driven by long-range interactions.
by: Mathias Ferber, et al.
Published: (2012-01-01)

Human APOBEC3 Variations and Viral Infection
by: Shiva Sadeghpour, et al.
Published: (2021-07-01)

HIV restriction by APOBEC3 in humanized mice.
by: John F Krisko, et al.
Published: (2013-03-01)

Defining and searching for structural motifs using DeepView/Swiss-PdbViewer
by: Johansson Maria U, et al.
Published: (2012-07-01)

Role of common human TRIM5α variants in HIV-1 disease progression
by: Ortiz Millàn, et al.
Published: (2006-08-01)

APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
by: Tegwinde Rebeca Compaore, et al.
Published: (2016-01-01)

A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans.
by: Yusuke Nakano, et al.
Published: (2020-09-01)

Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
by: Michael A Carpenter, et al.
Published: (2023-11-01)

Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies.
by: Samantha J Ziegler, et al.
Published: (2018-01-01)

Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association
by: Hirofumi Fukuda, et al.
Published: (2019-05-01)

Clinical use of pharmacogenomics
by: Telenti Amalio
Published: (2012-05-01)

Host genome influences on susceptibility to HIV-1
by: Telenti Amalio
Published: (2009-09-01)

CEM-T4 cells do not lack an APOBEC3G cofactor.
by: Guylaine Haché, et al.
Published: (2009-07-01)

Retraction: the cellular source for APOBEC3G's incorporation into HIV-1
by: Ma Jing, et al.
Published: (2011-11-01)